BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16431925)

  • 1. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells.
    Lu J; Lin WH; Chen SY; Longnecker R; Tsai SC; Chen CL; Tsai CH
    J Biol Chem; 2006 Mar; 281(13):8806-14. PubMed ID: 16431925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
    Fotheringham JA; Coalson NE; Raab-Traub N
    J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
    Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
    J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction.
    Fruehling S; Longnecker R
    Virology; 1997 Sep; 235(2):241-51. PubMed ID: 9281504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LMP2A protein of Epstein-Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases.
    Dergai O; Dergai M; Skrypkina I; Matskova L; Tsyba L; Gudkova D; Rynditch A
    Cell Signal; 2013 Jan; 25(1):33-40. PubMed ID: 22975684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation.
    Fukuda M; Kawaguchi Y
    J Virol; 2014 May; 88(9):5189-94. PubMed ID: 24554661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells.
    Zhou X; Matskova L; Rathje LS; Xiao X; Gish G; Werner M; Ignatyev I; Yu N; Zhao W; Tian F; Hou B; Zhang Z; Pawson T; Chen F; Ernberg I
    Oncogene; 2015 Aug; 34(34):4491-9. PubMed ID: 25531330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
    Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
    Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.
    Scholle F; Longnecker R; Raab-Traub N
    J Virol; 1999 Jun; 73(6):4767-75. PubMed ID: 10233937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.
    Winberg G; Matskova L; Chen F; Plant P; Rotin D; Gish G; Ingham R; Ernberg I; Pawson T
    Mol Cell Biol; 2000 Nov; 20(22):8526-35. PubMed ID: 11046148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein.
    Matskova LV; Helmstetter C; Ingham RJ; Gish G; Lindholm CK; Ernberg I; Pawson T; Winberg G
    Oncogene; 2007 Jul; 26(34):4908-17. PubMed ID: 17311000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma.
    Du ZM; Kou CW; Wang HY; Huang MY; Liao DZ; Hu CF; Chen J; Yan LX; Hu LF; Ernberg I; Zeng YX; Shao JY
    Head Neck; 2012 Oct; 34(10):1456-64. PubMed ID: 22287277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.
    Engels N; Merchant M; Pappu R; Chan AC; Longnecker R; Wienands J
    J Exp Med; 2001 Aug; 194(3):255-64. PubMed ID: 11489945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
    Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
    Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling.
    Morrison JA; Raab-Traub N
    J Virol; 2005 Feb; 79(4):2375-82. PubMed ID: 15681438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
    Ikeda M; Ikeda A; Longan LC; Longnecker R
    Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease.
    Cooper L; Longnecker R
    Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
    Hatton O; Lambert SL; Krams SM; Martinez OM
    PLoS One; 2012; 7(8):e42610. PubMed ID: 22880054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
    Swart R; Fruehling S; Longnecker R
    Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.
    Ingham RJ; Raaijmakers J; Lim CS; Mbamalu G; Gish G; Chen F; Matskova L; Ernberg I; Winberg G; Pawson T
    J Biol Chem; 2005 Oct; 280(40):34133-42. PubMed ID: 16087662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.